Delivery Order SPE2DB22D9133-SPE2DB24FYV36
Award Date 11/13/23
Potential Completion Date 11/14/23
Potential Value $23K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at fifty-six thousand, seven hundred eighty-seven dollars ($56,787) by the Defense Logistics Agency to provide NUCALA 100 MG/ML SYRINGEML. This delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to supply pharmaceutical items and medical products with a potential value of up to five million dollars ($5,000,000) through...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $18,929 by the Defense Logistics Agency to supply NUCALA 100 MG/ML SYRINGEML. This order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to provide pharmaceuticals and medical supplies with a total potential value of up to $5 million through December 2025. As a woman-owned small business, DMS Pharmaceutical Group will deliver the...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty-seven thousand eight hundred fifty-eight dollars by the Defense Logistics Agency to supply NUCALA 100 MG/ML SYRINGEML. This delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to provide pharmaceuticals and medical supplies with a potential value of up to five million dollars through December 2025. As a woman-owned...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $3,785.80 under an indefinite delivery contract with the Defense Logistics Agency to supply NUCALA 100 MG/ML SYRINGEML. As a woman owned small business and woman owned business, DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides prescription and over-the-counter drug supplies to the Department of Defense through numerous contracts and delivery orders. This delivery order is issued...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $13,250.30 under an indefinite delivery contract with the Defense Logistics Agency to supply NUCALA 100 MG/ML auto-injectors. As a woman-owned small business, DMS Pharmaceutical Group will provide the pharmaceutical items to DLA Troop Support Medical facilities. The delivery order has a completion date of December 15, 2023. DMS Pharmaceutical Group currently supplies various medical products to the Defense...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $9,464.50 from the Defense Logistics Agency Troop Support Medical to provide NUCALA 100 MG/ML auto-injectors. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency, which has a potential value of up to $5 million through December 2025. Under the indefinite delivery contract, DMS Pharmaceutical Group supplies pharmaceutical items and...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at one thousand eight hundred ninety-two dollars and ninety cents ($1,892.90) by the Defense Logistics Agency Troop Support Medical. The delivery order is for the supply of NUCALA 100 MG/ML auto-injectors to fulfill requirements through November 30, 2023. DMS Pharmaceutical Group Inc. will provide the pharmaceutical items under an existing indefinite delivery contract with the Defense Logistics Agency,...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $3,785.80 under an indefinite delivery contract with the Defense Logistics Agency to supply NUCALA 100 MG/ML auto-injectors. As a woman-owned small business, DMS Pharmaceutical Group provides pharmaceutical and medical supplies to support military treatment facilities worldwide. The delivery order was awarded on December 4, 2023 and requires completion by December 5, 2023. DMS Pharmaceutical Group currently...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at eleven thousand three hundred fifty-seven dollars and forty cents ($11,357.40) by the Defense Logistics Agency Troop Support Medical. The delivery order is for NUCALA 100 MG/ML SYRINGEML to fulfill requirements under the agency's indefinite delivery contract with DMS Pharmaceutical Group. This contract provides pharmaceutical items and medical supplies with a potential value of up to five million dollars...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $3,785.80 under an indefinite delivery contract with the Defense Logistics Agency to supply NUCALA 100MG/ML 1ML 1S. The delivery order has no set-aside designation and performance is to be completed by December 15, 2023. As a woman-owned small business and woman-owned business, DMS Pharmaceutical Group holds this pharmaceutical prime vendor contract vehicle with the Defense Logistics Agency to directly supply...